A recently published article in Healthcare IT News predicts that the global market for EHR vendors will grow at a rate of 15.3 percent over the next seven years. This growth will mean that clinical decision support and the drug nomenclature that is incorporated into these systems will be evaluated with a more critical eye than ever. With the new meaningful use requirements that are soon to be implemented, more clinicians will be exposed to drug interaction, duplicate therapy, drug allergy, and dosage range alerts than at any other time.
With this paradigm shift in the way healthcare is being delivered, it will be paramount that these systems provide accurate, meaningful clinical decision support and avoid the pitfalls of alert fatigue. Now is the time clinicians should demand that the clinical systems that are implemented have quality alerting and drug reference information based on current clinical guidelines.
With this paradigm shift in the way healthcare is being delivered, it will be paramount that these systems provide accurate, meaningful clinical decision support and avoid the pitfalls of alert fatigue. Now is the time clinicians should demand that the clinical systems that are implemented have quality alerting and drug reference information based on current clinical guidelines.
Powered by Compendium
Comments for Growth in HIS will put clinical decision support in the spotlight